Hyperliquid Strategies (PURR) Q2 2026 earnings summary

Executive summary

• Focused on maximizing NAV per share through strategic HYPE token and share buybacks, leveraging market conditions for accretive capital deployment.

• Completed a reverse recapitalization and acquisition of Sonnet, transforming into a cryptocurrency treasury company focused on HYPE tokens and maintaining biotech operations through Sonnet.

• Established the largest digital asset treasury for HYPE, raising $299.9 million in cash and receiving 12.5 million HYPE tokens via PIPE financing and contributions.

• Listed on Nasdaq under the ticker PURR as of December 3, 2025, following a business combination with Sonnet BioTherapeutics Holdings, Inc.

• Engaged a world-class team with deep traditional finance and crypto expertise to bridge the gap between digital and traditional assets.

Financial highlights

• Net loss of $318 million for the six months ending December 31, 2025, driven by $169 million accounting loss on HYPE commitment, $35.6 million IPR&D write-off from Sonnet acquisition, and $93 million unrealized loss from HYPE price decline.

• Cash and cash equivalents at period end were $282 million; HYPE digital assets had a fair value of $327 million (12.9 million tokens).

• Generated $1.4 million in interest and staking income; revenue for the period was $0.5 million, entirely from staking HYPE tokens.

• Total assets of $616.7 million and stockholders' equity of $589.8 million as of December 31, 2025.

• No debt obligations beyond short-term liabilities; $18 million deferred tax liability recognized.

Outlook and guidance

• Strong cash position and HYPE price rebound in January position the company well for continued treasury strategy execution.

• Management expects existing resources to fund operations for at least the next twelve months.

• Plans to maintain 100% of HYPE holdings staked unless superior opportunities arise and is evaluating medium-term participation as a validator in the Hyperliquid ecosystem.

• Monitoring regulatory developments, including the Clarity Act, for potential catalysts.

• Upcoming innovations such as portfolio margin and prediction markets expected to enhance capital efficiency and unlock new use cases.